Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 1075-1080, October 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armaghan, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Armaghan, V.

Effect of Chemotherapy on IRC 741 Leukemia in Fischer Rats

I. Development of Attenuated and Resistant Sublines*

Veronica Armaghan

( Cancer Research Laboratory, University of Miami, Coral Gables, Florida)

Preliminary observations were made on the survival time of Fischer rats given transplants of sublines of IRC 741 leukemia obtained from rats that had been treated with various compounds. Some of the donor rats had received treatment beginning the day after tumor transplantation, and treatment of others had been initiated 10 days after tumor transplantation. Rats given transplants of tumor tissue from donors that had received treatment beginning on day 1 seemed to live longer than recipients of tumor tissue from donors that had received treatment beginning on day 10. Experiments with five alkylating agents and one antibiotic supported this observation.

In addition, chemotherapy of rats bearing tumors from previously treated donors demonstrated that early treatment of donors attenuated the malignancy of the tumor and made it more responsive to treatment. Tumors from donor rats that had received treatment beginning on day 10 were resistant to treatment when transplanted into recipient hosts.

* This investigation was supported by research grant CY2498 from the National Cancer Institute, National Institutes of Health, Public Health Service.

Received 5/ 9/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.